相关实验视频
Updated: Jan 10, 2026

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
18.3K
直接作用的抗病毒治疗对感染HCV的T2DM患者的血糖控制的影响:使用孟德尔随机分析的观察研究
Jie Tang1, Jian Zhou2, Liyao Zhu1
1Department of Hepatology, The Fourth Hospital of Huai'an, Huai'an, Jiangsu, P. R. China.
Medicine
|November 20, 2025
概括
直接作用的抗病毒药物 (DAA) 提供暂时改善2型糖尿病 (T2DM) 控制的肝炎C病毒 (HCV) 患者. 长期的血糖控制需要除了病毒根除之外的综合管理策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
- 遗传学 遗传学 是一个
背景情况:
- 肝炎C病毒 (HCV) 感染与代谢障碍,如2型糖尿病 (T2DM) 有关.
- 直接作用的抗病毒药物 (DAA) 在HCV根除中有效.
- DAA对同感染患者T2DM管理的影响需要进一步调查.
研究的目的:
- 研究DAA对HCV和T2DM患者的血糖控制的影响.
- 探索对DAA代谢反应的潜在遗传调节剂.
主要方法:
- 针对HCV抗体阳性个体的NHANES数据 (1999-2018) 的横截面分析.
- 用DAA (2020-2023) 治疗T2DM患者的回顾性队列研究.
- 使用eQTL和pQTL数据对DAA目标基因进行门德尔随机化分析.
主要成果:
- 在6个月内,DAA治疗显示出HbA1c和禁食葡萄糖的显著短期改善.
- 这些代谢改善在治疗后12-18个月没有持续.
- 肝硬化或BMI异常的患者没有表现出短期代谢益处.
- 门德尔的随机化表明CXCL10在调节HbA1c中的作用.
结论:
- 用DAA消除HCV为T2DM患者提供了暂时的代谢益处.
- 持续的血糖控制需要除了抗病毒治疗之外的综合管理策略.
- 肝硬化和BMI等个别因素可能会影响对DAA的代谢反应.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes: Management and Pharmacotherapy
851
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
851
Oral Hypoglycemic Agents: Biguanides and Glitazones
567
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
567
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Retrovirus Life Cycles
49.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.2K
Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K

